Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Neurocrine Biosciences Inc (NBIX)  
$135.41 1.25 (0.91%) as of 4:30 Fri 5/31


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 93,430,000
Market Cap: 12.65(B)
Last Volume: 1,537,370 Avg Vol: 807,227
52 Week Range: $91.19 - $143.74
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  946
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Neurocrine Biosciences is applying its capabilities into neuroscience to develop medicines for neurology, neuroendocrinology and neuropsychiatry-related disorders and diseases. Co.'s commercially available medicines include INGREZZA®, which provides a once-daily dosing treatment option for tardive dyskinesia and has three dosing options (40 mg, 60 mg and 80 mg capsules); and ONGENTYS®, which is a once-daily, peripherally acting Catechol-O-methyltransferase inhibitor utilized to prolong the duration of effect of levodopa, the primary treatment option for Parkinson's disease patients, during periods of the day where the effects of levodopa wear off and motor symptoms worsen.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 257,175 839,572 900,370 1,367,577
Total Sell Value $35,466,379 $111,513,141 $118,219,229 $170,181,697
Total People Sold 9 17 17 18
Total Sell Transactions 19 74 92 161
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 1060
  Page 13 of 43  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lloyd-Smith Malcolm Chief Regulatory Officer   •       –      –    2021-01-25 4 AS $119.95 $2,107,812 D/D (17,570) 29,002 -21%     
   Lloyd-Smith Malcolm Chief Regulatory Officer   •       –      –    2021-01-25 4 OE $32.99 $605,470 D/D 17,570 37,960     -
   Benevich Eric Chief Commercial Officer   •       –      –    2021-01-25 4 AS $120.03 $609,371 D/D (5,077) 15,805 -21%     
   Benevich Eric Chief Commercial Officer   •       –      –    2021-01-25 4 OE $41.78 $145,269 D/D 3,477 20,882     -
   Gorman Kevin Charles Chief Executive Officer   •       •      –    2021-01-08 4 AS $110.21 $33,973,877 D/D (308,250) 441,071 -18%     
   Gorman Kevin Charles Chief Executive Officer   •       •      –    2021-01-08 4 OE $8.65 $2,667,797 D/D 308,250 605,872     -
   Roberts Eiry Chief Medical Officer   •       –      –    2021-01-08 4 AS $111.06 $292,297 D/D (2,632) 15,845 -18%     
   Sherwin Stephen A Director   –       •      –    2020-12-03 4 GD $0.00 $0 D/D 2,806 27,055     -
   Abernethy Matt Chief Financial Officer   •       –      –    2020-12-01 4 AS $94.66 $155,721 D/D (1,645) 11,494 -2%     
   Benevich Eric Chief Commercial Officer   •       –      –    2020-11-12 4 AS $90.71 $204,723 D/D (2,257) 17,405 8%     
   Bozigian Haig P. Chief Development Officer   •       –      –    2020-11-12 4 AS $90.74 $204,806 D/D (2,257) 152,694 8%     
   Cooke Julie Chief Human Resources Officer   •       –      –    2020-11-12 4 AS $90.73 $204,778 D/D (2,257) 11,580 8%     
   Gorman Kevin Charles Chief Executive Officer   •       •      –    2020-11-12 4 AS $90.78 $307,748 D/D (3,390) 441,071 8%     
   Lloyd-Smith Malcolm Chief Regulatory Officer   •       –      –    2020-11-12 4 AS $90.73 $204,776 D/D (2,257) 29,002 8%     
   Grigoriadis Dimitri E. Chief Research Officer   •       –      –    2020-11-12 4 AS $90.73 $204,784 D/D (2,257) 81,624 8%     
   Gano Kyle Chief Business Development Off   •       –      –    2020-11-12 4 AS $90.73 $204,770 D/D (2,257) 98,028 8%     
   Lippoldt Darin Chief Legal Officer   •       –      –    2020-11-12 4 AS $90.72 $204,755 D/D (2,257) 30,082 8%     
   Roberts Eiry Chief Medical Officer   •       –      –    2020-11-12 4 AS $90.74 $204,810 D/D (2,257) 13,477 8%     
   Abernethy Matt Chief Financial Officer   •       –      –    2020-11-12 4 AS $90.74 $204,810 D/D (2,257) 10,014 8%     
   Benevich Eric Chief Commercial Officer   •       –      –    2020-11-02 4 AS $96.53 $1,987,972 D/D (20,595) 15,374 1%     
   Benevich Eric Chief Commercial Officer   •       –      –    2020-11-02 4 OE $35.99 $741,214 D/D 20,595 35,969     -
   Cooke Julie Chief Human Resources Officer   •       –      –    2020-10-02 4 AS $95.26 $94,022 D/D (987) 9,549 21%     
   Lloyd-Smith Malcolm Chief Regulatory Officer   •       –      –    2020-08-05 4 AS $118.86 $268,277 D/D (2,257) 26,971 -17%     
   Cooke Julie Chief Human Resources Officer   •       –      –    2020-08-05 4 AS $118.91 $268,383 D/D (2,257) 8,661 -17%     
   Benevich Eric Chief Commercial Officer   •       –      –    2020-08-05 4 AS $118.85 $268,254 D/D (2,257) 15,374 -17%     
  1060 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 13 of 43
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us